-
Lyon a different proposition for Arsenal this time round, says Giraldez
-
Marc Marquez wins chaotic rain-affected Spanish MotoGP sprint
-
Gunfire in Mali as army battles 'terrorist groups'
-
Gunfire rocks Mali districts, including junta stronghold: witnesses
-
Welsh football icon Ramsey takes on marathon challenge for charity
-
Aussie Rules fires appeals chair over ruling on anti-gay slur
-
Lakers' OT win puts Rockets on brink of NBA playoff elimination
-
From radiation to invasion: a Chernobyl worker's two wars
-
AI firms flex lobbying muscle on both side of Atlantic
-
First female Archbishop of Canterbury to meet Pope Leo
-
Hundreds of firefighters battle Japan forest blazes
-
Lakers down Rockets in overtime for 3-0 series lead, Celtics hold off Sixers
-
US envoys heading to Pakistan for uncertain Iran talks
-
'Hockey is religion': Montreal fans pack church for playoff push
-
Billionaire Elon Musk enters courtroom showdown with OpenAI
-
Crunch nuclear proliferation meeting at UN amid raging global wars
-
Awkward debut for Trump at correspondents' dinner
-
Under blackout threat, Wikimedia reaches compromise with Indonesia
-
'Going to the moon': Irish footballers return to China 50 years after historic tour
-
Spurs' Wembanyama ruled out of game 3 after concussion
-
Palestinians to vote in first elections since Gaza war
-
Pragmatism, not patriotism, pushes young Lithuanians to military service
-
Good Driver Club Redesigns Its Website and App to Bring Transparency into Clearer View
-
Good Driver Club Publishes Eligible Events in Full Each Monday
-
The Story Behind Good Driver Club: Why Good Drivers Deserve to Keep More
-
Group Seeking Court Order to Halt CMS Medicare THC Hemp Marijuana Program
-
Peru confirms election runoff date, court says no to Lima re-vote
-
Venezuela, Colombia pledge military cooperation on first post-Maduro visit
-
US hopes for progress, but Iran says not direct talks
-
Maine governor nixes data center moratorium in state
-
Betis's Bellerin further dents Real Madrid title hopes
-
Lens rally but title bid fades after draw at Brest
-
OpenAI CEO apologizes to Canada town for not reporting mass shooter
-
UK PM vows legislation to ban Iran Guards: report
-
Leipzig tighten top-four grip as Union's Eta suffers second loss
-
Furyk named USA captain for 2027 Ryder Cup
-
EU, US sign critical minerals plan to counter China reliance
-
The 'housewives' did well -- Ukraine takes drone know-how abroad
-
Court removes US businessman from managing his Brazilian football team
-
'Natural' birth control risks unwanted pregnancy, experts warn
-
No.2 Korda boosts LPGA Chevron lead to seven
-
EU trade chief seeks 'positive traction' on US steel tariffs
-
Anthropic says Google to pump $40 bn into AI startup
-
Kohli makes Gujarat pay as Bengaluru cruise to IPL win
-
One injured in bomb attack on Colombia military base
-
Envoys from Iran, US expected in Pakistan for new talks
-
ILO names US official as number two amid grumbling over unpaid dues
-
Son of director Rob Reiner pays tribute to slain parents
-
AI united Altman and Musk, then drove them apart
-
Sinner overcomes Bonzi in record hunt at Madrid Open
A New Era in Patient Affordability: TailorMed Builds the Industry Infrastructure to Tackle Medication Costs at Scale
Facing Soaring Drug Prices, TailorMed's Affordability Network Bridges Care and Financial Relief
NEW YORK, NY / ACCESS Newswire / April 24, 2025 / Millions of Americans today face an impossible choice between affording life-saving medications and risking severe financial hardship. TailorMed is tackling this challenge by bringing healthcare providers, specialty pharmacies, life science companies, and patients together in one coordinated network - streamlining access to financial assistance so patients can stay on-therapy and achieve better outcomes.
On April 29, at 4:00 p.m. PT during Asembia AXS25, TailorMed CEO and co-founder Srulik Dvorsky will moderate "It Takes a Network: Tackling Affordability Together," joined by senior leaders from Pfizer, Walgreens Specialty Pharmacy, MetroHealth, and Pink Fund. This strategic roundtable will demonstrate how TailorMed's collaborative network turns these partnerships into real-world solutions that ease patient financial burdens and improve care.
"The soaring cost of medications is creating an untenable situation for patients, forcing too many to choose financial stability over essential treatments," said Dvorsky. "Our colleagues at Pfizer, Walgreens, Pink Fund, and MetroHealth share our passion and recognize the need to fundamentally change how affordability is managed, and ensure patients can access vital treatments without financial hardship. We are grateful that our partners will join this panel discussion to share their expertise."
TailorMed's extensive affordability network, the largest of its kind, ensures patients find the care pathways they need, when they need them. By bringing together healthcare providers, specialty pharmacies, life science companies, and nonprofit organizations, TailorMed leverages cutting-edge technology and collaborative partnerships to eliminate financial barriers, dramatically improving patient outcomes and easing systemic healthcare burdens.
TailorMed representatives will also be available throughout the summit at booth #2014 for discussions and demonstrations of their affordability solutions.
For additional information on TailorMed's innovative approaches to medication affordability, visit https://tailormed.co/.
About TailorMed
TailorMed is a comprehensive platform dedicated to removing financial barriers across the medication continuum - from affordability and access to adherence. TailorMed transforms healthcare collaboration among patients, providers, pharmacies, life sciences companies, and payers, ensuring every patient receives the treatments they need promptly. With the nation's largest Affordability Network deployed in more than 800 hospitals, 1,300 clinics, and 1,400 pharmacies, TailorMed enables stakeholders to deliver seamless patient experiences and drive better healthcare outcomes. Learn more at tailormed.co.
Media Contact:
Jennifer Martin, VP, Marketing
312.882.4402 | [email protected]
PR Contact:
Glenn Goldberg
Parallel Communications Group
+1 516 776-3282
LinkedIn
𝕏: @Parallel_PR
[email protected]
SOURCE: TailorMed
View the original press release on ACCESS Newswire
B.Finley--AMWN